12 amino acid analog epi-position of human b cell specificity membrane molecule CD20 and polypeptide epi-position vaccine configurated by said analog epi-position
Patent Information
- Authority / Receiving Office
- CN ยท China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- FOURTH MILITARY MEDICAL UNIVERSITY
- Publication Date
- 2006-06-14
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medical biotechnology, and specifically relates to screening of phage randomly presented peptide libraries, affinity detection and sequencing of screened phages, synthesis and coupling of polypeptides, animal immunization experiments, in vitro activity detection of induced antiserum and the like. It further relates to a 12-amino acid mimic epitope of human B cell-specific membrane molecule CD20 and a polypeptide epitope vaccine constructed by using the mimic epitope and capable of inducing autoantibodies against CD20 molecules in vivo. Background technique
[0002] 1. Research on CD20 molecule and its monoclonal antibody
[0003] 1.1 CD20 molecule
[0004] The CD20 molecule is a marker molecule expressed on the surface of more than 95% of normal or deteriorated B cells, and is an ideal target antigen for the treatment of B cell lymphoma. The gene encoding CD20 is located in the t(11...